Welcome to LookChem.com Sign In|Join Free

CAS

  • or

111991-19-6

Post Buying Request

111991-19-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

111991-19-6 Usage

Physical state

Colorless to pale yellow liquid

Odor

Strong, fruity

Usage

Flavoring agent in the food industry; intermediate in the pharmaceutical industry for drug synthesis; chemical intermediate in the production of insecticides and agrochemicals

Safety precautions

Flammable; may cause skin, eye, and respiratory irritation

Check Digit Verification of cas no

The CAS Registry Mumber 111991-19-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,9,9 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 111991-19:
(8*1)+(7*1)+(6*1)+(5*9)+(4*9)+(3*1)+(2*1)+(1*9)=116
116 % 10 = 6
So 111991-19-6 is a valid CAS Registry Number.

111991-19-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(2,4,6-trifluorophenyl)acetaldehyde

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:111991-19-6 SDS

111991-19-6Relevant articles and documents

INHIBITORS OF JANUS KINASES

-

Page/Page column 42, (2010/01/12)

The instant invention provides for compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2) and PDK1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3, TYK2 and PDK1 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 111991-19-6